Last Friday, CMS issued a memo to State Survey Agency Directors directing increased scrutiny of Nursing Homes. According to Mcknight's, this means: "Surveyors are being directed to place special attention on things such as nurse staff abilities and actions, use of antipsychotics and areas of care where residents’ health and safety may be at an increased risk. That means having a more critical eye on unplanned weight loss, loss of function/mobility, depression, abuse/neglect or pressure … [Read more...] about Tougher Surveys for Nursing Homes on the Horizon
As of November 8, 2021, Texas Health & Human Services has adopted a new rule regarding ICF Medicaid bed reallocation. The new rule “allows any person to request reallocated ICF/IID Medicaid beds from HHSC.” The new rule can be found here: … [Read more...] about New Bed Allocation Rule for ICF’s.
Cari Lalande is the Director of Clinical Pharmacogenomics at RxGenomix and Owner and Clinical Consultant Pharmacist at Precision Rx Consulting. She has a passion for improving "the quality of life for each patient by maximizing the efficacy of necessary drug therapy, eliminating polypharmacy and improving patient compliance." She shares her passion with us today. … [Read more...] about Grand Rounds Legal: Pharmacogenomics and Patient-Specific Medication Management
Tamar Bibbs assists growers and others with risk mitigation. She is the CEO of IV20 Houston, LLC. During her interview, she highlights areas of concern of which those in the business should be aware. Jerri Lynn Ward · Grand Rounds Legal--Mitigating Risks in Hemp & CBD … [Read more...] about Grand Rounds Legal: Mitigating Risks in the Hemp and CBD Industry with Tamar Bibbs
This is the reason for the new letter: Some ICF/IID program providers have reported having difficulty obtaining a physician signature on an intellectual disability/related condition (ID/RC) assessment form due to the COVID-19 pandemic. In response, the Texas Health and Human Services Commission (HHSC) is advising providers to renew an individual’s level of care that expired in March, April, or May as explained in this letter if the program provider did not get a physician’s signature on … [Read more...] about July 8, 2020 Texas HHS Provider Letter to (ICF/IID) Program Providers
HHS has published Provider Letter PL2020-29 regarding the new Texas Administrative Code Rules and amendments governing Administrative Penalties, informal dispute resolution and amelioration for the above providers. The rules took effect April 28, 202, however the administrative penalty portion will not impact violations identified prior to September 1, 2020. Stay tuned to this blog for further details. … [Read more...] about Home and Community-based Services and Texas Home Living Provider Letter
Since the legalization of CBD oil a little less than a year ago, the already massive interest in using it has greatly increased in Texas. People with conditions that reputedly can benefit want to try it. Some of those people might be residents in your nursing home, assisted living center, group home or home health program. This episode will discuss things you need to know about CBD oil and medical cannabis. With me to discuss this is Lisa Mahfouz Morris of Lakeway Botanicals. … [Read more...] about Grand Rounds Legal: What Health Providers Should Know about Medical Cannabis and CBD Oil with Lisa Mahfouz Morris of Lakeway Botanicals
CMS arranged and paid for an investigation by the U.S. Government Accountability Office (GAO) to look at quality measures pertaining to Hospice which found troubling results. Previously, the OIG had identified "that 18 percent of all hospices in a nationwide survey had serious deficiencies, like failing to vet staff." The GAO report concluded that ..."eighty for-profits failed to send registered nurses, physicians or nurse practitioners to visit discharged patients even … [Read more...] about GAO Gives Troubling Report Regarding Lack of End-of-Life Visits by Hospice
Replacing the stethoscope. https://youtu.be/q2S8NlTk_8I … [Read more...] about The Butterfly IQ–Changing the Future of Medicine?
The Drug Enforcement Administration (DEA) announced on Monday that is is taking steps to expand the number of federally authorized marijuana manufacturers for research purposes. In the three years since DEA first said it would be accepting applications for cannabis manufacturers, the agency has received 33 submissions. In a notice of applications set to be published in the Federal Register on Tuesday, DEA said the “unprecedented” volume of inquiries makes it necessary to develop new … [Read more...] about DEA to Finally Take Action on Marijuana Grower Applications